VistaGen Therapeutics Inc (VTGN)

[Johnny_C]

Very good article that does a good job explaining the path VTGN should follow.

https://marketexclusive.com/vistagen-therapeutics-17m-company-potentially-2-8b-drug/2017/07/

The article did not distinguish that NAUREX was sold to Allergan after Phase II and in addition to the initial 560 million payment Allergan is paying trailing back end milestones of about 1.1 billion dollars. That would bring the total to about 1.8 billion payout for NAUREX with Allergan assuming all the risk and expense of completing Phase III and filing the NDA.

One fact I was not aware of until recently is that an acquiring company generally would prefer to complete Phase III or at least step in prior to the filing of the NDA with a drug that has so many indications because the acquirer would want to tailor the NDA to the indications that fit their model.

Very good info though, I would suggest going through the companies website and checking out the videos.

The depression market is enormous and it i